Despite attempts to minimize bias through a systematic and comprehensive search strategy, unpublished or negative studies may have been overlooked
Chen K, Yu G (2024) Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of A1-42 and tau through regulation of PI3K/Akt signaling pathway
Rodent studies have found it to be about 2.5 times more anabolic muscle-building than IGF-1 (11)
It can lead to subsequent yellow-orange discoloration (xanthoderma or carotenoderma) and their subsequent deposition in the outermost layer of skin
K.KukalS.KanojiaN.SasoL.KukretiS.KukretiR
The consensus statement recommends GLP-1/GIP therapy for: Adults with T1D who have overweight or obesity (BMI of 30 or higher, or 27 or higher with other health conditions) Adults with T1D who arent hitting their blood sugar goals with insulin alone, even at a healthy weight Teens and young adults with T1D who have overweight or obesity and arent reaching their targets on insulin or who are meeting targets but might still benefit If your BMI drops below 25, or was 25 or under when treatment started, your healthcare provider should check in regularly and may pause or stop the medication altogether